Cargando…

Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study

OBJECTIVE: Patients with short bowel syndrome (SBS) and colon in continuity have better adaptation potential compared with patients with jejunostomy. Adaptation may involve enhanced postprandial secretion of the enteroendocrine hormones glucagon-like peptide (GLP)-1 and GLP-2 which are normally degr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naimi, Rahim Mohammad, Hvistendahl, Mark Krogh, Thomassen, Lise Margrete, Johnsen, Hanna, Christiansen, Charlotte Bayer, Holst, Jens Juul, Hartmann, Bolette, Jeppesen, Palle Bekker
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Intestinal Failure
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117993/ https://www.ncbi.nlm.nih.gov/pubmed/33975891 http://dx.doi.org/10.1136/bmjgast-2021-000604

Ejemplares similares

Endoscopic ultrasound in the monitoring of the intestinal allograft
por: Oltean, Mihai, et al.
Publicado: (2022)

The first cases of collagenous sprue successfully treated with thioguanine
por: van Gils, Tom, et al.
Publicado: (2016)

Intestinal stem cells promote crypt fission during postnatal growth of the small intestine
por: Dudhwala, Zenab Mustansir, et al.
Publicado: (2020)

Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysis
por: Liu, Jing, et al.
Publicado: (2020)

Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals
por: Davis, Joseph A., et al.
Publicado: (2010)

Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin
por: Wilson, Jessica R., et al.
Publicado: (2017)

Dipeptidyl Peptidase-4 Inhibition in Patients with Type 2 Diabetes Treated with Saxagliptin, Sitagliptin, or Vildagliptin
por: Tatosian, Daniel A., et al.
Publicado: (2013)

The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes
por: Kubota, Yoshiaki, et al.
Publicado: (2012)

Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
por: Mega, Cristina, et al.
Publicado: (2017)

Severe edema and blood blisters of the lower extremities caused by sitagliptin, a dipeptidyl peptidase‐4 inhibitor
por: Maita, Hiroki, et al.
Publicado: (2021)

Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Phosphate Accelerates Cellular Cholesterol Efflux in THP-1 Cells
por: Komatsu, Tomohiro, et al.
Publicado: (2023)

Obstrucción intestinal/
por: Welch, Claude E.
Publicado: (1959)

Rat salivary gland ligation causes reversible secretory hypofunction
por: Carpenter, G H, et al.
Publicado: (2007)

Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice
por: Tam, Clarence C, et al.
Publicado: (2011)

Generation of primary human intestinal T cell transcriptomes reveals differential expression at genetic risk loci for immune-mediated disease
por: Raine, Tim, et al.
Publicado: (2015)

Initial Experience of Video Capsule Endoscopy After Intestinal Transplantation
por: Varkey, Jonas, et al.
Publicado: (2016)

Gut microbiota associated with HIV infection is significantly enriched in bacteria tolerant to oxygen
por: Dubourg, Grégory, et al.
Publicado: (2016)

Robotic-Assisted Live Donor Ileal Segmentectomy for Intestinal Transplantation
por: Wu, Guosheng, et al.
Publicado: (2017)

Identical Twin Small-bowel Transplantation Without Maintenance Immunosuppression: A 5-year Follow-up and Literature Review
por: Wu, Guosheng, et al.
Publicado: (2018)

Outcomes of Adult Intestinal Transplant Recipients Requiring Dialysis and Renal Transplantation
por: Puttarajappa, Chethan M., et al.
Publicado: (2018)

Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts
por: Volkmann, Elizabeth R, et al.
Publicado: (2017)

Immunologic Complications and Graft Survival in Crohn’s Disease and NOD2 Mutant Non-Crohn’s Disease Adult Recipients Following Intestine Transplantation
por: Belyayev, Leonid, et al.
Publicado: (2020)

Safe and Successful Treatment of Acute Cellular Rejection of an Intestine and Abdominal Wall Transplant With Vedolizumab
por: Trentadue, Guido, et al.
Publicado: (2020)

Tacrolimus-Induced Optic Neuropathy After Multivisceral Transplantation
por: Canovai, Emilio, et al.
Publicado: (2019)

DNA methylation defines regional identity of human intestinal epithelial organoids and undergoes dynamic changes during development
por: Kraiczy, Judith, et al.
Publicado: (2019)

Preemptive VAE—An Important Tool for Managing Blood Loss in MVT Candidates With PMT
por: Borle, Deeplaxmi P., et al.
Publicado: (2021)

Graft Versus Host Disease After Intestinal Transplantation: A Single-center Experience
por: Kaufman, Stuart S., et al.
Publicado: (2021)

Orthotopic Transplantation of the Full-length Porcine Intestine After Normothermic Machine Perfusion
por: Abraham, Nader, et al.
Publicado: (2022)

The First Collective Examination of Immunosuppressive Practices Among American Intestinal Transplant Centers
por: Weiner, Joshua, et al.
Publicado: (2023)

Idiopathic Ileal Ulceration After Intestinal Transplantation
por: Hussan, Elsadig, et al.
Publicado: (2023)

Response to Letter to the Editor: “Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin”
por: Wilson, Jessica R, et al.
Publicado: (2020)

New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
por: Cui, Chenkai, et al.
Publicado: (2022)

GLP-1 and Intestinal Diseases
por: Hunt, Jenna Elizabeth, et al.
Publicado: (2021)

Effect of a Dipeptidyl Peptidase-IV Inhibitor, Des-Fluoro-Sitagliptin, on Neointimal Formation after Balloon Injury in Rats
por: Lim, Soo, et al.
Publicado: (2012)

The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Protects against Dyslipidemia-Related Kidney Injury in Apolipoprotein E Knockout Mice
por: Li, Jingjing, et al.
Publicado: (2014)

Dipeptidyl-Peptidase 4 Inhibitor Sitagliptin Ameliorates Hepatic Insulin Resistance by Modulating Inflammation and Autophagy in ob/ob Mice
por: Zheng, Wenbin, et al.
Publicado: (2018)

Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Muscle Mass and the Muscle/Fat Ratio in Patients With Type 2 Diabetes
por: Ishii, Satoshi, et al.
Publicado: (2020)

Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial
por: Naimi, Rahim Mohammad, et al.
Publicado: (2019)

Correction: Effect of a Dipeptidyl Peptidase-IV Inhibitor, Des-Fluoro-Sitagliptin, on Neointimal Formation after Balloon Injury in Rats
por: Lim, Soo, et al.
Publicado: (2012)

Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors
por: Shibasaki, Ikuko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r19qhv4raig39a1d5d293urmcm